Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NMRC submits revised IND to FDA to conduct Op RESUS trial of Biopure's Hemopure

Dec. 4, 2008

Novel agents for bone disorders disclosed in recent Sungkyunkwan University patent

Dec. 4, 2008

Lilly presents dual CCR2/CCR5 antagonist as antidiabetes, antiobesity candidate

Dec. 3, 2008

Enobia doses first infant patient in ERT trial of ENB-0040 for hypophosphatasia

Dec. 3, 2008

Genaera initiates phase Ib trial of MSI-1436 in overweight and obese type 2 diabetics

Dec. 3, 2008

Auxilium and Ferring sign European license agreement for Testim testosterone gel

Dec. 3, 2008

Novel CETP inhibitors for lipoprotein disorders disclosed in recent Kowa patent

Dec. 3, 2008

ViroPharma submits sBLA for Cinryze for hereditary angioedema

Dec. 2, 2008

Lexicon files IND with the FDA for LX-4211 as a potential treatment for diabetes

Dec. 2, 2008

FDA approves Duramed's synthetic conjugated estrogens-A cream

Dec. 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...